6-hydroxydopamine affects multiple pathways to induce cytotoxicity in differentiated LUHMES dopaminergic neurons

Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight

(2022) Mohammed Al-Azzani et al.   Biomolecules

Nrf2 Inhibits the Progression of Parkinson’s Disease by Upregulating AABR07032261.5 to Repress Pyroptosis

(2022) Yunxiao Zhong et al.   Journal of Inflammation Research

The Role of NEDD4 E3 Ubiquitin–Protein Ligases in Parkinson’s Disease

(2022) James A. Conway et al.   Genes

Carnosic Acid Alleviates Levodopa-Induced Dyskinesia and Cell Death in 6-Hydroxydopamine-lesioned Rats and in SH-SY5Y Cells

(2021) Chun-Yi Lai et al.   Frontiers in Pharmacology

Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson’s Disease: Roads to Biomarker Discovery

(2021) Anna Picca et al.   Biomolecules

Diagnosis and Treatment of Parkinson Disease

(2020) Melissa J. Armstrong et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The MT1G Gene in LUHMES Neurons Is a Sensitive Biomarker of Neurotoxicity

(2020) Zhi-Bin Tong et al.   NEUROTOXICITY RESEARCH

Activation of the Akt1-CREB pathway promotes RNF146 expression to inhibit PARP1-mediated neuronal death

(2020) Hyojung Kim et al.   Science Signaling

Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins

(2019) Noëlle Callizot et al.   PLoS One

Toxicity, recovery, and resilience in a 3D dopaminergic neuronal in vitro model exposed to rotenone

(2018) Georgina Harris et al.   ARCHIVES OF TOXICOLOGY

Prevention of neuronal apoptosis by astrocytes through thiol-mediated stress response modulation and accelerated recovery from proteotoxic stress

(2018) Simon Gutbier et al.   CELL DEATH AND DIFFERENTIATION

6-Hydroxydopamine induces nuclear translocation of apoptosis inducing factor in nigral dopaminergic neurons in rat

(2017) Hong-Il Yoo et al.   Molecular & Cellular Toxicology

Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson’s Disease

(2017) Debashis Dutta et al.   MOLECULAR NEUROBIOLOGY

El modelo de 6-hidroxidopamina y la fisiopatología parkinsoniana: nuevos hallazgos en un viejo modelo

(2017) D. Hernandez-Baltazar et al.   NEUROLOGIA

Cellular models for Parkinson's disease

(2016) Björn H. Falkenburger et al.   JOURNAL OF NEUROCHEMISTRY

A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis

(2015) L. Smirnova et al.   ARCHIVES OF TOXICOLOGY

6-OHDA-Induced Changes in Parkinson`s Disease-Related Gene Expression are not Affected by the Overexpression of PGAM5 in In Vitro Differentiated Embryonic Mesencephalic Cells

(2015) Tomasz Maciej Stępkowski et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Cell-based assays for Parkinson's disease using differentiated human LUHMES cells

(2014) Xiao-min Zhang et al.   ACTA PHARMACOLOGICA SINICA

The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons

(2014) Xi Lu et al.   Molecular Neurodegeneration

Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases

(2014) Stefan Schildknecht   ALTEX-Alternatives to Animal Experimentation

Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants

(2013) Anne K. Krug et al.   ARCHIVES OF TOXICOLOGY

Parkinson's disease cybrids, differentiated or undifferentiated, maintain morphological and biochemical phenotypes different from those of control cybrids

(2013) T.A. Appukuttan et al.   JOURNAL OF NEUROSCIENCE RESEARCH

A Guide to Neurotoxic Animal Models of Parkinson's Disease

(2013) K. Tieu   Cold Spring Harbor Perspectives in Medicine

The Role of Autophagy in Parkinson's Disease

(2013) M. A. Lynch-Day et al.   Cold Spring Harbor Perspectives in Medicine

Retinoic acid protects against proteasome inhibition associated cell death in SH-SY5Y cells via the AKT pathway

(2012) Benxu Cheng et al.   NEUROCHEMISTRY INTERNATIONAL

Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line

(2011) Diana Scholz et al.   JOURNAL OF NEUROCHEMISTRY

Insulin-like growth factor-I mediates neuroprotection in proteasome inhibition-induced cytotoxicity in SH-SY5Y cells

(2011) Benxu Cheng et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Dissociation of Progressive Dopaminergic Neuronal Death and Behavioral Impairments by Bax Deletion in a Mouse Model of Parkinson's Diseases

(2011) Tae Woo Kim et al.   PLoS One

Clinical progression in Parkinson disease and the neurobiology of axons

(2010) Hsiao-Chun Cheng et al.   ANNALS OF NEUROLOGY

α-Synuclein overexpression increases dopamine toxicity in BE(2)-M17 cells

(2010) Marco Bisaglia et al.   BMC NEUROSCIENCE

Costs of illness and care in Parkinson's Disease: An evaluation in six countries

(2010) Sonja von Campenhausen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells

(2009) Stefan Schildknecht et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells

(2008) Maria Gomez-Lazaro et al.   FREE RADICAL BIOLOGY AND MEDICINE